LAVA Therapeutics N.V. (LVTX) is a biopharmaceutical company specializing in the development of novel immunotherapeutic drugs. The company focuses on developing therapies that harness the natural abilities of the immune system to combat cancer and other diseases. LAVA Therapeutics focuses on researching and developing new treatment approaches, utilizing immune system-based technologies such as immune modulators and specific antigens. The company responds to the growing interest in new forms of cancer therapy and treatments based on the immune system. Shares of LAVA Therapeutics N.V. (LVTX) can be an interesting choice for investors tracking the biopharmaceutical and research sector.